Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2,4,6(1h,3h,5h)-pyrimidinetrione, 5-ethyl-5-(1-methylpropyl)-, Monosodium Salt
2. Butabarbital
3. Butabarbitone
4. Butisol
5. Butisol Sodium
6. Sarisol
7. Secbutabarbital
8. Secbutabarbital Sodium
9. Secbutobarbitone
10. Secumalum
1. Carrbutabarb
2. Asturidon
3. Barbitab
4. Bubartal
5. Butalan
6. Butasaron
7. Butased
8. Butazem
9. Buticaps
10. Cambrised
11. Ciprial
12. Expansatol
13. Insolat
14. Intasedol
15. Loubarb
16. Mebutal
17. Neravan
18. Noctinal
19. Prelital
20. Quiebar
21. Sarisol
22. Butak
23. Butatal Sodium
24. Butisol Sodium
25. Bubartal Tt
26. Butabarpal Sodium
27. Seda-bute
28. Sodium Butabarbital
29. Butabarbitone Sodium
30. Secbubarbital Sodium
31. Sodium Butobarbitone
32. Secbutobarbitone Sodium
33. Butabarbital Sodium [usp]
34. Sodium 5-ethyl-5-sec-butylbarbiturate
35. Sodium 5-sec-butyl-5-ethylbarbiturate
36. 143-81-7
37. Sodium 5-ethyl-5-(1-methylpropyl)barbiturate
38. Butabarbital Sodium (usp)
39. Paxital (van)
40. Sarisol No. 1
41. Secbutabarbital Sodique
42. Butibel
43. 2,4,6(1h,3h,5h)-pyrimidinetrione, 5-ethyl-5-(1-methylpropyl)-, Monosodium Salt
44. Sarisol No. 2
45. 9wtd50i918
46. Einecs 205-611-8
47. Nsc 11778
48. Unii-9wtd50i918
49. 5-sec-butyl-5-ethylbarbituric Acid Sodium Salt
50. Butabarb (tn)
51. 5-ethyl-5-(1-methylpropyl)barbituric Acid Sodium Salt
52. Butisol Sodium (tn)
53. Secbutabarbital Sodium (inn)
54. Schembl122121
55. Barbituric Acid, 5-sec-butyl-5-ethyl-, Sodium Salt
56. Chebi:3229
57. D00699
58. Q27273326
| Molecular Weight | 234.23 g/mol |
|---|---|
| Molecular Formula | C10H15N2NaO3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 234.09803663 g/mol |
| Monoisotopic Mass | 234.09803663 g/mol |
| Topological Polar Surface Area | 81.6 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 330 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Butisol sodium |
| PubMed Health | Butabarbital (By mouth) |
| Drug Classes | Sedative |
| Drug Label | BUTISOL SODIUM (butabarbital sodium tablets, USP and butabarbital sodium oral solution, USP) is a non-selective central nervous system depressant which is used as a sedative or hypnotic. It is available for oral administration as Tablets containing... |
| Active Ingredient | Butabarbital sodium |
| Dosage Form | Elixir; Tablet |
| Route | Oral |
| Strength | 30mg/5ml; 50mg; 30mg |
| Market Status | Prescription |
| Company | Meda Pharms |
| 2 of 2 | |
|---|---|
| Drug Name | Butisol sodium |
| PubMed Health | Butabarbital (By mouth) |
| Drug Classes | Sedative |
| Drug Label | BUTISOL SODIUM (butabarbital sodium tablets, USP and butabarbital sodium oral solution, USP) is a non-selective central nervous system depressant which is used as a sedative or hypnotic. It is available for oral administration as Tablets containing... |
| Active Ingredient | Butabarbital sodium |
| Dosage Form | Elixir; Tablet |
| Route | Oral |
| Strength | 30mg/5ml; 50mg; 30mg |
| Market Status | Prescription |
| Company | Meda Pharms |
Hypnotics and Sedatives
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)
ABOUT THIS PAGE
A Carrbutabarb manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Carrbutabarb, including repackagers and relabelers. The FDA regulates Carrbutabarb manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Carrbutabarb API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Carrbutabarb supplier is an individual or a company that provides Carrbutabarb active pharmaceutical ingredient (API) or Carrbutabarb finished formulations upon request. The Carrbutabarb suppliers may include Carrbutabarb API manufacturers, exporters, distributors and traders.
Carrbutabarb Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Carrbutabarb GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Carrbutabarb GMP manufacturer or Carrbutabarb GMP API supplier for your needs.
A Carrbutabarb CoA (Certificate of Analysis) is a formal document that attests to Carrbutabarb's compliance with Carrbutabarb specifications and serves as a tool for batch-level quality control.
Carrbutabarb CoA mostly includes findings from lab analyses of a specific batch. For each Carrbutabarb CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Carrbutabarb may be tested according to a variety of international standards, such as European Pharmacopoeia (Carrbutabarb EP), Carrbutabarb JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Carrbutabarb USP).
LOOKING FOR A SUPPLIER?
